Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Brii Biosciences (Brii Bio) Closes US$155 Million Series C Financing
Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet […]
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Eloxx Pharmaceuticals, Inc. today announced it has acquired Zikani Therapeutics, Inc. in an all-stock transaction, with […]
Omega Therapeutics to Advance Pipeline and Platform Development with Additional Financing
Omega Therapeutics, Inc. (“Omega“), a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to […]
Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform
Ro, the healthcare technology company, today announced it has completed a $500 million Series D […]
Chime Biologics Completes US$190M Series A+ Financing
Chime Biologics Limited, a China-based, world-class CDMO company, announced today that it has secured a total […]
Better Health Announces $3.5 Million Seed Funding To Build The Next-Generation Medical Supplier, Reinventing a $60B Market
Better Health, the next-generation medical supplier offering a seamless e-commerce experience and white-glove service to […]
Q'Apel Medical raises $22 Million to grow innovative Neurovascular access platform & Scott Huennekens joins Board of Directors
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]
Zocdoc raises $150 million
New York-based digital healthcare marketplace Zocdoc announced $150 million in growth financing from Francisco Partners, a […]
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the close of […]
Angelini Pharma and Trueblue: a new collaboration gets underway for optimising data-based decision making and analytics
Promoting the development of corporate decision-making process powered by the use of data, KPIs and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more